References
- Kawai T, et al. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant 2014; 14(7): 1599-611; PMID:24903438; http://dx.doi.org/10.1111/ajt.12731
- Leventhal J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4(124): 124ra28; PMID:22399264; http://dx.doi.org/10.1126/scitranslmed.3003509
- Scandling JD, et al. Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant 2015; 15(3): 695-704; PMID:25693475; http://dx.doi.org/10.1111/ajt.13091
- Barth RN, et al. Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am J Transplant 2011; 11(7): 1407-16; PMID:21668624; http://dx.doi.org/10.1111/j.1600-6143.2011.03551.x
- Schultz BD, et al. Early microchimerism after face transplantation detected by quantitative real-time polymerase chain reaction of insertion/deletion polymorphisms. Transplantation 2015; 99(7): e44-5; PMID:26147136; http://dx.doi.org/10.1097/TP.0000000000000745
- Lobashevsky AL, et al. Quantitative analysis of chimerism using a short tandem repeat method on a fluorescent automated DNA sequencer. Clin Lab Haematol 2006; 28(1): 40-9; PMID:16430459; http://dx.doi.org/10.1111/j.1365-2257.2006.00754.x
- Kim SY, et al. Chimerism monitoring after allogeneic hematopoietic stem cell transplantation using quantitative real-time PCR of biallelic insertion/deletion polymorphisms. J Mol Diagn 2014; 16(6): 679-88; PMID:25157970; http://dx.doi.org/10.1016/j.jmoldx.2014.06.005
- Wiegand P, Kleiber M. Less is more–length reduction of STR amplicons using redesigned primers. Int J Legal Med 2001; 114(4-5): 285-7; PMID:11355413; http://dx.doi.org/10.1007/s004140000162
- Dahmen UM, et al. Flow cytometric "rare event analysis": a standardized approach to the analysis of donor cell chimerism. J Immunol Methods 2002; 262(1-2): 53-69; PMID:11983219; http://dx.doi.org/10.1016/S0022-1759(02)00017-0
- Kishikawa H, et al. Early microchimerism in peripheral blood following kidney transplantation. Transplant Proc 2014; 46(2): 388-90; PMID:24655970; http://dx.doi.org/10.1016/j.transproceed.2013.12.036
- Gadi VK, et al. Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection. Clin Chem 2006; 52(3): 379-82; PMID:16397013; http://dx.doi.org/10.1373/clinchem.2005.058974
- Interewicz B, et al. DNA released from rejecting organs is an indicator of the degree of graft cellular damage. Transplant Proc 2005; 37(1): 98-101; PMID:15808560; http://dx.doi.org/10.1016/j.transproceed.2005.01.064
- Benitez C, et al. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013; 58(5): 1824-35; PMID:23532679; http://dx.doi.org/10.1002/hep.26426
- de la Garza RG, et al. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance. Liver Transpl 2013; 19(9): 937-44; PMID:23784747; http://dx.doi.org/10.1002/lt.23686